Publicacions en què col·labora amb Javier Salvador Rodríguez (68)

2021

  1. NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling

    Cellular and Molecular Immunology, Vol. 18, Núm. 4, pp. 1045-1057

  2. Resting energy expenditure is not altered in children and adolescents with obesity. Effect of age and gender and association with serum Leptin levels

    Nutrients, Vol. 13, Núm. 4

2020

  1. Aquaporin-11 Contributes to TGF-β1-Induced Endoplasmic Reticulum Stress in Human Visceral Adipocytes: Role in Obesity-Associated Inflammation

    Cells, Vol. 9, Núm. 6

  2. Dermatopontin, a novel adipokine promoting adipose tissue extracellular matrix remodelling and inflammation in obesity

    Journal of Clinical Medicine, Vol. 9, Núm. 4

  3. FNDC4, a novel adipokine that reduces lipogenesis and promotes fat browning in human visceral adipocytes

    Metabolism: Clinical and Experimental, Vol. 108

  4. Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 1, pp. 21-37

  5. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

    FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837

2019

  1. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation

    Nutrients, Vol. 11, Núm. 2

  2. Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes

    Aging, Vol. 11, Núm. 6, pp. 1733-1744

  3. Circulating concentrations of GDF11 are positively associated with TSH levels in humans

    Journal of Clinical Medicine, Vol. 8, Núm. 6

  4. GLP-1 limits adipocyte inflammation and its low circulating pre-operative concentrations predict worse type 2 diabetes remission after bariatric surgery in obese patients

    Journal of Clinical Medicine, Vol. 8, Núm. 4

  5. Increase of the adiponectin/leptin ratio in patients with obesity and type 2 diabetes after roux-en-y gastric bypass

    Nutrients, Vol. 11, Núm. 9

2018

  1. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589

  2. Increased Small Intestine Expression of Non-Heme Iron Transporters in Morbidly Obese Patients With Newly Diagnosed Type 2 Diabetes

    Molecular Nutrition and Food Research, Vol. 62, Núm. 2

  3. Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress

    Metabolism: Clinical and Experimental, Vol. 87, pp. 123-135

2017

  1. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: Relationship with metabolic outcomes

    International Journal of Obesity, Vol. 41, Núm. 9, pp. 1379-1387

  2. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss

    Clinical Nutrition, Vol. 36, Núm. 3, pp. 861-868

  3. IL-32α-induced inflammation constitutes a link between obesity and colon cancer

    OncoImmunology, Vol. 6, Núm. 7

  4. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Altered concentrations in dyslipidemia evidence a role for ANGPTL8/betatrophin in lipid metabolism in humans

    Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 10, pp. 3803-3811